Meng Zhou
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Hematology top 5%
- Iron Metabolism and Disorders
Papers in
-
- RNA Interference and Gene Delivery 7
- PI3K/AKT/mTOR signaling in cancer 4
- Immunology 13
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 4
- Co-authors
- Kelong Fan (10 shared papers)Xiyun Yan (10 shared papers)Demin Duan (1 shared paper)Jing Feng (1 shared paper)Minmin Liang (1 shared paper)Dongling Yang (1 shared paper)Kun Wang (2 shared papers)Jiuyang He (2 shared papers)
- Journals
- Cell Death and Disease (3 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Advanced Functional Materials (2 papers)Immunology Letters (2 papers)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Meng Zhou
45 papers receiving 2.0k citations
Meng Zhou's Hit Papers
Peers
Comparison fields: 5 of 110
- Biomaterials 457
- Hematology 321
- Immunology 383
- Pharmaceutical Science 98
- Molecular Biology 856
Countries citing papers authored by Meng Zhou
This map shows the geographic impact of Meng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Zhou more than expected).
Fields of papers citing papers by Meng Zhou
This network shows the impact of papers produced by Meng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Zhou. The network helps show where Meng Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Meng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | H-ferritin–nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection Hit paper breakdown → | 2014 | 438 |
| 2 | Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma Hit paper breakdown → | 2018 | 335 |
| 3 | 2018 | 139 | |
| 4 | 2011 | 110 | |
| 5 | 2019 | 103 | |
| 6 | 2019 | 100 | |
| 7 | 2020 | 61 | |
| 8 | 2016 | 53 | |
| 9 | 2022 | 53 | |
| 10 | 2012 | 51 | |
| 11 | 2021 | 50 | |
| 12 | 2013 | 44 | |
| 13 | Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium. | 2014 | 40 |
| 14 | 2016 | 31 | |
| 15 | 2014 | 29 | |
| 16 | 2013 | 26 | |
| 17 | 2021 | 26 | |
| 18 | 2013 | 25 | |
| 19 | 2021 | 22 | |
| 20 | 2017 | 22 |
About Meng Zhou
Meng Zhou is a scholar working on Molecular Biology, Immunology, Hematology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 48 papers that have together received 2.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Iron Metabolism and Disorders (6 papers), Immunotherapy and Immune Responses (5 papers), Nanoparticle-Based Drug Delivery (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Immune Cell Function and Interaction (4 papers), Advanced Drug Delivery Systems (4 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Biomaterials (457 citations), Hematology (321 citations), Immunology (383 citations), Pharmaceutical Science (98 citations) and Molecular Biology (856 citations). Meng Zhou has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Kelong Fan, Xiyun Yan, Demin Duan, Jing Feng, Minmin Liang, Dongling Yang, Kun Wang, Jiuyang He, Xiaohua Jia and Jie Tian. Their work appears in journals such as Cell Death and Disease, Journal of Experimental & Clinical Cancer Research, Advanced Functional Materials, Immunology Letters and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.